Doherty Catherine T.
EVP, Regional Businesses
Doherty Catherine T. has filed 4 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Mar 6, 2026.
On the most recent filing, Doherty Catherine T. is listed as EVP, Regional Businesses at QUEST DIAGNOSTICS INC. Inside the rolling window, Doherty Catherine T. reported no open-market purchases and 4 open-market sales totaling $7.0M in DGX. The largest disclosed transaction in the window is a sale of 26,165 DGX shares on Feb 13, 2026, worth $5.4M.
Companies traded
Other insiders at DGX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Doherty Catherine T. made?
Doherty Catherine T. has filed 4 SEC Form 4 filings (15 transaction rows) across 1 company since 2026.
Which companies does Doherty Catherine T. trade?
Doherty Catherine T. has filed SEC Form 4 disclosures for 1 company, including DGX.
When was Doherty Catherine T.'s most recent SEC Form 4 filing?
Doherty Catherine T.'s most recent SEC Form 4 filing on Tracefour is dated Mar 6, 2026.
What is Doherty Catherine T.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Doherty Catherine T. is listed as EVP, Regional Businesses.
What is Doherty Catherine T.'s total buy and sell value in the current window?
Inside the rolling retention window, Doherty Catherine T. bought $0 and sold $7.0M based on SEC Form 4 filings.
What was Doherty Catherine T.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 26,165 DGX shares on 2026-02-13, worth $5.4M, per SEC Form 4 filings.